What's breaking now, across thousands of outlets.
Despite having an allogeneic cell therapy prospect that’s ready for late-stage testing in lymphoma, Caribou couldn’t secure funding to support the effort and will now pursue “strategic alternatives” instead.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Rospotrebnadzor said nearly 5,000 tests found no dangerous pathogens and saw "no epidemic risk," while the Kremlin called most media reporting "false" and said it had no knowledge of a US demarche…
They would require safer supply drugs only be consumed under medical supervision
A possible plague outbreak in Russia is increasingly making headlines in the world’s media and drawing the attention of officials in the world’s leading countries. U.S.
A new McMaster University study of nearly half a million people has found that many people who go on to develop chronic pelvic pain (CPP) may have been showing warning signs years before diagnosis…
Cardiology professor Khaled Al-Nemer highlights eight situations where artificial heart valve patients should receive preventive antibiotics.
An expert digs into why ADHD is getting more attention now than ever on social media and what still gets lost in the conversation.
